Back

FRAGILE (French Attitude Registry in case of ICD Lead Replacement) preliminary results.

20 March 2018 (11:20 - 11:30)
Organised by:
Congress Presentation Part of: Shocking truths regarding implantable cardioverter defibrillators Device Complications and Lead Extraction EHRA Premium Access EHRA 2018

About the speaker

Photo
Doctor Christine Alonso

Clinique Medico-Chirurgicale Ambroise Pare, Neuilly sur Seine (France)

8 More presentations in this session

Presentation thumbnail
Striking difference between cardiac sub-specialties during consideration for implantable cardioverter defibrillators
Doctor A. Mistry (Nottingham, GB)
Abstract Slides Video
Presentation thumbnail
The destiny of abandoned transvenous ICD leads
Mr A. Elgaard (Aalborg, DK)
Abstract
Presentation thumbnail
Predictors and clinical impact of late ventricular arrhythmias in patients with continuous-flow left ventricular assist devices.
Doctor V. Galand (Rennes, FR)
Abstract
Presentation thumbnail
Single chamber implantable cardioverter defibrillator compared to dual chamber implantable cardioverter defibrillator. Less is more. Data from the German Device Registry
Doctor H. Bogossian (Hagen, DE)
Abstract
Presentation thumbnail
Is long detection ICD setting more useful in women? Data from the Advance III trial.
Abstract

Access the full session

Session thumbnail
Shocking truths regarding implantable cardioverter defibrillators

The Event

Event poster

EHRA 2018

20 March 2018 11:20 CET
You may be interested in
thumbnail
Congress Presentation
Prevalence and leading causes of transvenous lead extraction for nonfunctional leads in a real-world setting: a 5-year multicenter overview
13 April 2026
thumbnail
Congress Session
Evolution in pacing and risk management strategies in sudden cardiac death
31 March 2025
thumbnail
Congress Presentation
Midterm results of the LEADR trial confirm ongoing safety, efficacy, and reliability of the novel, small-diameter OmniaSecure defibrillation lead
31 March 2025
thumbnail
Congress Session
Cardiac pacing and cardiac resynchronisation therapy
30 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources